Inventor · disambiguated record
Manouchehr Shahbaz
Also filed as: SHAHBAZ MANOUCHEHR · SHAHBAZ MANOUCHEHR M
12 granted patents·47 pending applications·155 citations·filing 2001–2025
92Inventor score
Top patents by PatentIndex Score
59 records- 0194US9296739B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Mar 29, 2016·21 cites·27 claims
- 0294US9233959B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Jan 12, 2016·22 cites·27 claims
- 0394US7374891B2Methods to identify compounds that modulate rageTRANSTECH PHARMA INC·Filed 2004·Granted May 20, 2008·64 cites·26 claims
- 0490US9814708B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·6 cites·39 claims
- 0590US9346800B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2013·Granted May 24, 2016·9 cites·20 claims
- 0689US2024366591A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0787US8252933B22-oxo-1,2-dihydro-quinoline modulators of immune functionGANT THOMAS G·Filed 2009·Granted Aug 28, 2012·11 cites·28 claims
- 0884US2025326747A1Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0983US8227451B2Phenylacetic acid inhibitors of cyclooxygenaseGANT THOMAS G·Filed 2009·Granted Jul 24, 2012·2 cites·54 claims
- 1083US6908741B1Methods to identify compounds that modulate RAGETRANSTECH PHARMA INC·Filed 2001·Granted Jun 21, 2005·15 cites·21 claims
- 1182US9550780B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Jan 24, 2017·4 cites·27 claims
- 1281US11033540B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2019·Granted Jun 15, 2021·0 cites·38 claims
- 1381US2022267317A1Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1477US2021244723A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1574US2020347048A1Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1673US11666566B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2020·Granted Jun 6, 2023·0 cites·18 claims
- 1772US2019375746A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1869US2019083484A1Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1969US2015080427A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2069US2014350044A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2168US2014206712A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2268US2014206713A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2367US2017166562A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2466US2016367548A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2566US2020000794A1Benzoquinolone inhibitors of vmat2AUSPEX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2666US2013296360A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2766US2016375005A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2865US2010143505A1Indanone inhibitors of acetylcholinesteraseAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2965US2016220558A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3064US10387114B1System to assist visually impaired userSHAHBAZ MANOUCHEHR·Filed 2018·Granted Aug 20, 2019·1 cites·16 claims
- 3164US2015080426A1Benzoquinoline inhibitors of vmat 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3264US2016158220A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3363US2017087147A1Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3462US2015328207A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3560US2017246159A1Benzoquinolone inhibitors of vmat2AUSPEX PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3660US2008293163A1Methods to identify compounds that modulate rageTRANSTECH PHARMA INC·Filed 2008·Application pending·0 cites
- 3756US2010074973A1Thioxanthene modulators of dopamine d2 receptorsAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3855US2016030414A1Benzoquinoline inhibitors of vmat 2AUSPEX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3954US2010160272A1Oxepine modulators of h1 receptors and/or inhibitors of mast cell degranulationAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4053US2010124550A1Amide inhibitors of reninAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4153US2010167988A1Ethoxyphenylmethyl inhibitors of sglt2AUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4253US2010135956A1Steroid modulators of progesterone receptor and/or glucocorticoid receptorAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4353US2010124541A1Hydroxyadamantyl inhibitors of dipeptidylpeptidase ivAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4453US2010125094A1Pyrrolidinyl modulators of nicotinic acetylcholine receptorsAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4553US2010125085A1Pyridoindole modulators of nmda receptor and acetylcholinesteraseAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4653US2010120733A1Steroid modulators of glucocorticoid receptorAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4753US2010137332A1Piperazine modulators of nk-1 receptorsAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4853US2011091459A1Imidazole modulators of muscarinic acetylcholine receptor m3AUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4953US2010076074A1Carbamate reducers of skeletal muscle tensionAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 5053US2010111901A1Triazole inhibitors of aromataseAUSPEX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →